Cargando…

First experiences in treatment of low-grade glioma grade I and II with proton therapy

BACKGROUND: To retrospectively assess feasibility and toxicity of proton therapy in patients with low-grade glioma (WHO °I/II). PATIENTS AND METHODS: Proton beam therapy only administered in 19 patients (median age 29 years; 9 female, 10 male) for low-grade glioma between 2010 and 2011 was reviewed....

Descripción completa

Detalles Bibliográficos
Autores principales:	Hauswald, Henrik, Rieken, Stefan, Ecker, Swantje, Kessel, Kerstin A, Herfarth, Klaus, Debus, Jürgen, Combs, Stephanie E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527266/ https://www.ncbi.nlm.nih.gov/pubmed/23140402 http://dx.doi.org/10.1186/1748-717X-7-189

Ejemplares similares

Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas
por: Kosaki, Katsura, et al.
Publicado: (2012)

Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma
por: Harrabi, S. B., et al.
Publicado: (2016)

Carbon Ion Beam Reirradiation in Recurrent High-Grade Glioma
por: Eberle, Fabian, et al.
Publicado: (2020)

Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3
por: Eichkorn, Tanja, et al.
Publicado: (2023)

Ion therapy within the trimodal management of superior sulcus tumors: the INKA trial
por: Hauswald, Henrik, et al.
Publicado: (2015)

Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data
por: Combs, Stephanie E, et al.
Publicado: (2012)

Whole Blood Transcriptional Fingerprints of High-Grade Glioma and Longitudinal Tumor Evolution under Carbon Ion Radiotherapy
por: Knoll, Maximilian, et al.
Publicado: (2022)

Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma
por: Hauswald, Henrik, et al.
Publicado: (2012)

Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location
por: Adeberg, Sebastian, et al.
Publicado: (2018)

Treatment of meningioma and glioma with protons and carbon ions
por: Adeberg, Sebastian, et al.
Publicado: (2017)

Targeting α(ν)β(3 )and α(ν)β(5 )inhibits photon-induced hypermigration of malignant glioma cells
por: Rieken, Stefan, et al.
Publicado: (2011)

Optimization of carbon ion and proton treatment plans using the raster-scanning technique for patients with unresectable pancreatic cancer
por: Dreher, Constantin, et al.
Publicado: (2015)

Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts
por: Rieken, Stefan, et al.
Publicado: (2012)

Single-dose radiosurgical treatment for hepatic metastases - therapeutic outcome of 138 treated lesions from a single institution
por: Habermehl, Daniel, et al.
Publicado: (2013)

Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

Impact of (18)F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy
por: Debus, Charlotte, et al.
Publicado: (2018)

Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy
por: Habermehl, Daniel, et al.
Publicado: (2013)

Multiparametric MRI-based differentiation of WHO grade II/III glioma and WHO grade IV glioblastoma
por: Wiestler, Benedikt, et al.
Publicado: (2016)

Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study
por: Nikoghosyan, Anna V, et al.
Publicado: (2010)

Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma
por: Hauswald, Henrik, et al.
Publicado: (2015)

Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patients
por: Regnery, Sebastian, et al.
Publicado: (2020)

Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response
por: Jensen, Alexandra D, et al.
Publicado: (2011)

A trend towards a more intense adjuvant treatment of low-grade-gliomas in tertiary centers in Germany after RTOG 9802 – results from a multi-center survey
por: Straube, Christoph, et al.
Publicado: (2018)

Prior surgical intervention and tumor size impact clinical outcome after precision radiotherapy for the treatment of optic nerve sheath meningiomas (ONSM)
por: Adeberg, Sebastian, et al.
Publicado: (2011)

Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy
por: Guillevin, R, et al.
Publicado: (2011)

Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning
por: El Shafie, Rami A., et al.
Publicado: (2018)

Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma
por: El Shafie, Rami A., et al.
Publicado: (2018)

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

Radiotherapeutic alternatives for previously irradiated recurrent gliomas
por: Combs, Stephanie E, et al.
Publicado: (2007)

The impact of tumor metabolic activity assessed by (18)F-FET amino acid PET imaging in particle radiotherapy of high-grade glioma patients
por: Waltenberger, Maria, et al.
Publicado: (2022)

Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma
por: Osman, Mohammed A
Publicado: (2014)

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate - first results of the PLATIN 1 trial
por: Habl, Gregor, et al.
Publicado: (2015)

Total skin electron beam therapy as palliative treatment for cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia
por: Hauswald, Henrik, et al.
Publicado: (2012)

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
por: Habermehl, Daniel, et al.
Publicado: (2012)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Current therapeutic approaches to diffuse grade II and III gliomas
por: Picca, Alberto, et al.
Publicado: (2018)

Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy
por: Murphy, P S, et al.
Publicado: (2004)

Proton minibeam radiation therapy widens the therapeutic index for high-grade gliomas
por: Prezado, Yolanda, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vedkg1ni6amdab4e3j0h3dgdr8